• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Oxbotica to develop multi-purpose self-driving vehicle with AppliedEV

September 7, 2021 by David Barret Leave a Comment

September 7, 2021

By Nick Carey

LONDON (Reuters) – Self-driving software startup Oxbotica said on Wednesday it has teamed up AppliedEV to develop a fully autonomous multi-purpose vehicle that could be suitable for a variety of commercial uses.

The first deployments of the self-driving electric vehicles (EVs) will be in industrial logistics and automated goods delivery.

“We have an ambitious deployment goal over the coming years, driven by an extraordinary market appetite for a world-class product,” Oxbotica founder Paul Newman said in a statement.

In April, British online grocer Ocado said it would invest 10 million pounds ($13.8 million) in Oxbotica as part of a tie-up that aims to reduce the cost of last-mile delivery and other logistics.

“We are really excited and supportive of this collaboration between Oxbotica and AppliedEV as we see it as an important step on our journey to developing advanced autonomous mobility solutions for the Ocado Smart Platform,” said Alex Harvey, head of advanced technology at Ocado Technology.

AppliedEV, an autonomous EV maker founded by former Tesla Inc and General Motors Co executives, will provide the EV platform for the vehicle.

AppliedEV Chief Executive Julian Broadbent said the partnership could bring “strong commercial outcomes” in as little as 12 months.

In January, Oxbotica said it had raised $47 million in a funding round led by the venture arm of oil giant BP and which included health and safety device maker Halma Plc and Tencent.

($1 = 0.7255 pounds)

(Reporting By Nick Carey; Editing by Cynthia Osterman)

Source Link Oxbotica to develop multi-purpose self-driving vehicle with AppliedEV

David Barret
David Barret

Related posts:

  1. UK card spending slips to 93% of pre-COVID level – ONS
  2. Your next smartwatch could come with not one, but two cameras on board
  3. GM to cut North American production, citing chip shortage
  4. Fujifilm confirms it’s working on high-resolution mirrorless cameras

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Neolithic Ireland Wasn’t Ruled By Incestuous “God-Kings” After All
  • NASA’s Voyager 1 & 2 Were Not The First Missions To Reach The Outer Solar System
  • See Incredible First Images From Space Mission That Will Weigh All The World’s Forests
  • Nudes Of The Stone Age: 6,000-Year-Old Kołobrzeg Venus Is A Prehistoric Masterpiece
  • Cannabis And Human Remains Sent To Space Go Missing After Returning To Earth On SpaceX Mission
  • Mercury’s Steep Cliffs Might Be The Result Of The Sun Squeezing The Planet
  • Dennis Hope: The Man Who Allegedly Sold Presidents Land On The Moon (That He Doesn’t Own)
  • Video: Which Animal Has The Largest Brain?
  • Amazing First Images From World’s Largest Digital Camera Revealed
  • There’s Only One Person In The World With This Blood Type
  • Garden Snails Now Venomous According To Radical Redefinition, And Things Get Surprisingly Sexy
  • “Allokelping”: Hot New Wellness Trend For Critically Endangered Orcas Showcases Impressive Tool Use
  • Beam Of Light Shone All The Way Through A Human Head For The Very First Time
  • “On My Participation In The Atomic Bomb Project”: Einstein’s Powerful Letter Goes Up For Auction For $150,000
  • Watch Friendly Dolphins Help Lead A Lost Humpback Whale Into Deeper Waters
  • World’s Largest Digital Camera Snaps 2,104 New Asteroids And Millions Of Galaxies Within A Few Hours
  • Cat Or Otter? The Jaguarundi Looks Like Both
  • “The Sea Shall Flow To Jackdaw’s Well”: Old English Mermaid Legend Traced Back Centuries
  • The Fungus Blamed For “Tutankhamun’s Curse” Could Make A Potent Anti-Cancer Drug
  • Space Might Be A Byproduct Of Three-Dimensional Time
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version